SYMPOSIUM 3: COVID-19 VACCINE DEVELOPMENT

AACR, BioNTech US
7/20/20, 5:15 PM
America/New York GMT -4 summer

Description

SYMPOSIUM 3: COVID-19 VACCINE DEVELOPMENT

2:20-4:20 P.M.

Introduction

E. John Wherry, University of Pennsylvania, Philadelphia, Pennsylvania

 

Rapid SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness

Kizzmekia S. Corbett, National Institutes of Allergy and Infectious Diseases (NIAID), Bethesda Maryland

 

Pan-HLA prediction of SARS-CoV-2 epitopes*

Katie M. Campbell, University of California, Los Angeles, California

 

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes*

Asaf Poran, BioNTech US, Cambridge, Massachusetts

 

A computational approach to identify a possible SARS-CoV-2 vaccine from receptor binding domain peptide sequence on spike glycoproteins*

Majid Al-Zahrani, King Abdulaziz University, Jeddah, Saudi Arabia

 

Synthetic DNA for EID outbreaks including SARS-CoV2

David Weiner, The Wistar Institute, Philadelphia, Pennsylvania

 

Closing Remarks / Discussion

E. John Wherry

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

E. John Wherry

Inglês

 

Speakers

Kizzmekia S. Corbett, Majid Al-Zahran, Asaf Poran, David Weiner

 

Link to the Event

Banner to the Event

SYMPOSIUM 3: COVID-19 VACCINE DEVELOPMENT